Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $552.31 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $161.48 | 3 | $0 (2024) |
| Medtronic, Inc. | $156.24 | 1 | $0 (2024) |
| Melinta Therapeutics, LLC | $154.13 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $49.47 | 3 | $0 (2024) |
| Radius Health, Inc. | $17.77 | 1 | $0 (2022) |
| Genentech USA, Inc. | $13.22 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $304.64 | 7 | Medtronic, Inc. ($156.24) |
| 2023 | $64.27 | 4 | AstraZeneca Pharmaceuticals LP ($31.98) |
| 2022 | $45.20 | 2 | Melinta Therapeutics, LLC ($27.43) |
| 2018 | $13.22 | 1 | Genentech USA, Inc. ($13.22) |
| 2017 | $124.98 | 1 | PFIZER INC. ($124.98) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $156.24 | General |
| Category: Renal Denervation System | ||||||
| 12/06/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: ANTIBIOTICS | ||||||
| 08/01/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: ANTIBIOTICS | ||||||
| 06/13/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: ANTIBIOTICS | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Rare Disease | ||||||
| 05/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/18/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: ANTIBIOTICS | ||||||
| 12/13/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/12/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: ANTIBIOTICS | ||||||
| 06/06/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Rare Disease | ||||||
| 03/13/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Rare Disease | ||||||
| 12/04/2022 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Vabomere | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: ANTIBIOTICS | ||||||
| 06/28/2022 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Endocrinology | ||||||
| 11/28/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Metabolism & Primary Care | ||||||
| 09/20/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,631 | 1,829 | $1.4M | $213,548 |
| 2022 | 6 | 1,108 | 1,143 | $552,589 | $140,102 |
| 2021 | 9 | 1,221 | 1,239 | $721,532 | $158,643 |
| 2020 | 5 | 524 | 535 | $376,702 | $73,465 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 592 | 603 | $720,369 | $101,035 | 14.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 253 | 257 | $430,812 | $51,692 | 12.0% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 181 | 183 | $125,500 | $20,356 | 16.2% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 41 | 52 | $29,075 | $8,910 | 30.6% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 44 | 44 | $19,011 | $5,809 | 30.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 61 | 84 | $21,586 | $5,279 | 24.5% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 27 | 33 | $12,697 | $3,899 | 30.7% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 56 | 56 | $19,687 | $3,735 | 19.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 25 | $11,175 | $3,056 | 27.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $10,047 | $2,923 | 29.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 18 | 18 | $5,238 | $1,364 | 26.0% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 15 | 19 | $4,346 | $1,327 | 30.5% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 34 | 38 | $4,788 | $1,194 | 24.9% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 21 | 34 | $2,652 | $665.52 | 25.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 19 | 38 | $1,900 | $616.36 | 32.4% |
| 99282 | Emergency department visit with straightforward medical decision making | Facility | 2023 | 11 | 11 | $2,095 | $427.69 | 20.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 57 | 59 | $3,564 | $393.30 | 11.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 35 | $525.00 | $294.00 | 56.0% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 18 | 18 | $846.00 | $222.56 | 26.3% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 11 | 16 | $688.00 | $145.82 | 21.2% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 38 | 45 | $533.00 | $90.49 | 17.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 13 | $325.00 | $44.33 | 13.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 34 | 103 | $1,080 | $41.75 | 3.9% |
| J0692 | Injection, cefepime hydrochloride, 500 mg | Office | 2023 | 14 | 28 | $198.00 | $27.63 | 14.0% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 506 | 528 | $230,621 | $59,071 | 25.6% |
About Joseph Zito, MD, MHA
Joseph Zito, MD, MHA is a Emergency Medicine healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1649441429.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joseph Zito, MD, MHA has received a total of $552.31 in payments from pharmaceutical and medical device companies, with $304.64 received in 2024. These payments were reported across 15 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($552.31).
As a Medicare-enrolled provider, Zito has provided services to 4,484 Medicare beneficiaries, totaling 4,746 services with total Medicare billing of $585,758. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Critical Care Medicine
- Location Manhasset, NY
- Active Since 03/19/2008
- Last Updated 04/23/2013
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1649441429
Products in Payments
- ELIQUIS (Drug) $161.48
- SYMPLICITY G3 (Device) $156.24
- Kimyrsa (Drug) $154.13
- ANDEXXA (Biological) $49.47
- Tymlos (Biological) $17.77
- Activase (Biological) $13.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Manhasset
Christopher Raio, Md, MD
Emergency Medicine — Payments: $187,256
Joshua Levine, Md, MD
Emergency Medicine — Payments: $13,958
Laura Patruno, Pa, PA
Emergency Medicine — Payments: $5,785
Jason Zemmel D'amore, Md, MD
Emergency Medicine — Payments: $4,719
Dr. Tadeusz Korszun, Md, MD
Emergency Medicine — Payments: $2,243
David Silver, Md, MD
Emergency Medicine — Payments: $1,153